Анестезин

Quick links

Choose a section

Quick links to important sections

Advertisements

Анестезин

Advertisements
Advertisements
Advertisements

Overview of Анестезин

Quick Facts

Property Description
Active ingredient Benzocaine
Form Powder, solution, ointment, and topical preparations
Pharmacological class Local Anesthetic (Amino Ester Type)
Common purpose Surface symptomatic pain relief
Origin Synthetic organic compound

What is Анестезин and What is its Pharmacological Classification?

Анестезин is the widely recognized name for the active pharmaceutical ingredient Benzocaine, which is categorized as a local anesthetic of the amino ester class. Its pharmacological function is exclusively to achieve surface anesthesia, offering targeted relief from localized pain. This compound is chemically defined as ethyl 4-aminobenzoate, a synthetic organic compound. This classification is based on its chemical structure and its primary mechanism of nerve membrane stabilization.

The drug entity is characterized as a single-ingredient product, focusing its therapeutic effect entirely on the properties of the Benzocaine component. Its classification as an amino ester distinguishes it from amide-type local anesthetics, such as Lidocaine, defining its unique metabolic pathway and chemical structure.

Composition, Origin, and Available Forms

The composition of Анестезин centers on the Benzocaine active ingredient, which is prepared as various topical preparations for surface administration. These common dosage forms include powders, solutions, and ointments, each utilizing non-active bases or vehicles—such as oil, alcohol, or cream—to facilitate effective topical application. Benzocaine is typically positioned for application in minor skin irritations or mild mucosal discomfort, representing a common over-the-counter (OTC) approach to localized pain management in many regions.

The General Purpose of Анестезин

The general purpose of Анестезин is to afford temporary, localized symptomatic relief from pain and discomfort by inducing a state of effective surface anesthesia. This fundamental benefit is delivered without the drug needing to enter the systemic circulation to produce its effect. The substance acts by inhibiting the electrical signals necessary for pain transmission across nerve membranes. The temporary nature of its nerve impulse blockade mechanism is key to its role as a supportive, localized analgesic.

Regulatory References

  1. Benzocaine mechanism on MedlinePlus
Advertisements

What side effects are possible with Анестезин?

Possible side effects and safety information

The official regulatory safety profile for Анестезин (Benzocaine) is defined by documented localized reactions and the potential for a serious, systemic blood disorder, as classified by government health authorities.

Serious Adverse Reactions

Methemoglobinemia is officially listed as a rare, serious, and potentially life-threatening blood disorder, categorized under Blood and Lymphatic System Disorders. This condition reduces the blood's capacity to carry oxygen. Symptoms associated with this risk, as documented in regulatory labels, include pale, gray, or blue-colored skin ( cyanosis), shortness of breath, headache, and rapid heart rate. These symptoms may appear within minutes to one or two hours after application, and can occur even if the medicine has been used previously.

Localized and Hypersensitivity Reactions

The most commonly encountered adverse reactions affect the Immune System Disorders and Skin and Subcutaneous Tissue Disorders. These include localized hypersensitivity reactions such as burning, stinging, itching ( pruritus), redness ( erythema), and localized swelling or rash at the site of application. Contact dermatitis is also documented as a possible adverse reaction, which may be associated with prolonged or repeated use.

Population-Specific Safety Considerations

Official labels enforce specific constraints on use for certain populations due to the risk of Methemoglobinemia. The use of Анестезин is contraindicated in children younger than 2 years of age. Older adults and individuals with pre-existing conditions such as breathing problems or heart disease are also cited as being at greater risk for complications from this disorder. Additionally, use is contraindicated in patients with a history of allergy to ester-type local anesthetics or PABA.

Advertisements

Overdose and Emergency Response

The official regulatory profile for an overdose of Анестезин (Benzocaine) centers on the life-threatening risk of methemoglobinemia, a severe blood disorder where oxygen transport is compromised. This serious outcome is often associated with over-application or high-concentration use.

Documented clinical manifestations of methemoglobinemia include visible signs of systemic hypoxia, such as cyanosis (a pale, gray, or blue discoloration of the skin, lips, or nail beds), severe headache, shortness of breath, fatigue, and a rapid heart rate.

Systemic overdose may also result in Central Nervous System (CNS) effects. These effects are officially described as progressing from initial excitation—including tremors, ringing in the ears, and blurred vision—to severe CNS depression, which can potentially lead to loss of consciousness and respiratory arrest.

Immediate medical attention is required if any signs of methemoglobinemia or systemic toxicity are observed after using the product. Regulatory guidance mandates immediately stopping use and contacting emergency services. Management is officially defined as symptomatic and supportive care, with the specific antidote, Methylene blue, documented for the required reversal of clinically significant methemoglobinemia. Official labeling also highlights that infants and children younger than 2 years of age have an increased susceptibility to this serious complication.

Advertisements

Therapeutic Uses of Анестезин

What Анестезин Treats: Main Uses and Benefits

The primary therapeutic role of Анестезин (Benzocaine) is to provide temporary, localized numbing for various superficial discomforts. It is relevant in clinical settings that involve acute or unstable symptom patterns where managing pain, itching, and sensory irritation is the immediate priority.

This topical anesthetic is commonly used across conditions presenting with acute episodes of localized pain and discomfort. Specific applications include easing pain from minor cuts, superficial abrasions, minor sunburn, insect stings, canker sores, mouth ulcers, sore gums, and external hemorrhoids. The medication is applied when symptoms create noticeable functional strain, providing support that helps ease the overall symptom burden.

Therapeutic Domains and Symptom Management

Pain Relief for Minor Skin and Environmental Irritations

This domain covers acute episodes of discomfort on the skin surface. It is used to ease the burning, stinging, and localized pain associated with minor cuts, superficial abrasions, or skin reactions to irritant plants. The medication helps ease the overall symptom burden and supports the patient during difficult episodes.

Management of Oral and Pharyngeal Soreness

Анестезин is applicable in situations involving painful or sore mucous membranes of the mouth and throat. It helps address symptom clusters that may become intense, supporting the patient during difficult episodes by contributing to easing the overall symptom load.


Quick Fact: Relief for Localized Discomfort The medication is primarily used to offer short-term symptomatic assistance for managing acute, minor, and episodic pain, burning, and itching across skin and mucosal surfaces.

Support for Anorectal Discomfort

The medication is relevant in episodic symptomatic phases marked by increased discomfort in the anorectal area. It is applied to address localized patterns of pain, burning, and intense itching associated with conditions such as external hemorrhoids or minor anal fissures. The temporary numbing action is relevant when supportive symptom management is appropriate and assists with maintaining functional stability.

Regulatory References

  1. DailyMed official label for Benzocaine oral anesthetic
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Анестезин — official regulatory information

Eligibility scope

Scope Item Official Regulatory Statement
Populations for whom use is allowed (as stated in label): Adults and Children 2 years of age and older for approved topical uses.
Populations for whom use is not recommended (if applicable): Older adults (Geriatric patients); Individuals with breathing or heart problems; Pregnant and breastfeeding women (unless benefits outweigh risks).
Populations for whom use is contraindicated: Infants and children younger than 2 years of age; Individuals with a known allergy to Benzocaine or related anesthetics; Patients with a family history of methemoglobinemia.
Age-related eligibility rules: ABSOLUTELY CONTRAINDICATED in children under 2 years. Conditional use permitted for children 2 years and older. Use in older adults is restricted due to greater risk.
Condition-specific eligibility rules: Contraindicated for individuals with specific inborn metabolic defects, such as G6PD deficiency, that increase the risk of adverse blood conditions.
Pregnancy and lactation eligibility status (if explicitly documented): RESTRICTED status. Use is conditional, requiring benefit to outweigh potential risk to the fetus or infant. Not recommended for application to the breast/nipple during lactation.
Eligibility-related restrictions: Contraindication based on documented risk in susceptible populations. Restricted use based on increased risk severity in the elderly and patients with certain cardiopulmonary comorbidities.

Eligibility classifications (high-level)

Classification Item Regulatory Basis
Eligibility severity classification (as defined in official documents): Contraindicated; Restricted/Conditional Use; Greater Risk.
Regulatory basis (EMA / FDA / etc.): FDA Drug Safety Communication / EMA National SmPC.
Eligibility-context constraints (as defined in official documents): The primary constraint is the officially documented risk of methemoglobinemia in high-risk groups.

Connection to the overall eligibility profile

Regulatory documents define who can and cannot use the medicine primarily through an absolute prohibition for infants under two years of age, and for individuals with known hypersensitivity or certain genetic enzyme deficiencies. Eligibility is further structured by restrictions placed on older adults and patients with underlying breathing or heart conditions, who are officially categorized as being at a greater risk. Use during pregnancy and lactation is permitted only conditionally.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Анестезин (Benzocaine) primarily focuses on pharmacodynamic and chemical interactions, as documented by government health authorities. The interaction profile is structured around two key areas: additive toxicity risk and chemical incompatibility.

Documented Pharmacodynamic Interactions

Benzocaine carries an additive risk of methemoglobinemia when co-administered with other substances that also induce this condition. These interactions are clinically significant and documented in regulatory safety communications:

  • Methemoglobin-Inducing Agents: Co-administration with nitrate derivatives (e.g., Nitroglycerin), Dapsone, or other local anesthetics may increase the severity or likelihood of methemoglobin formation.
  • Dietary Agents: This additive risk also extends to co-exposure with high levels of nitrites and nitrates found in certain foods or water.

Interaction-Related Restrictions and Contraindications

Two significant restrictions are noted in official labeling:

  • Sulfonamide Antibiotics: Co-administration with sulfonamide antibiotics is formally restricted because Benzocaine, being an amino ester, can be metabolized into a substance that chemically antagonizes the antibacterial action of the sulfonamides.
  • Population-Specific Contraindication: Over-the-counter oral Benzocaine products are contraindicated for use in infants and children younger than 2 years due to a heightened and severe risk of the methemoglobinemia outcome, which represents a population-based interaction caution.

Other Considerations

Official documents do not typically detail clinically relevant classic pharmacokinetic interactions (e.g., CYP enzyme inhibition or induction) for topical Benzocaine preparations. Herbal products such as St. John's Wort have been noted in government-aligned interaction data, warranting precaution.

Advertisements

Mechanism of Action

Benzocaine is an ester-type local anesthetic that acts by modulating neuronal membrane excitability. The compound, possessing lipophilic characteristics, readily permeates the lipid bilayer of the nerve cell membrane in its un-ionized form. Once inside the axoplasm, it becomes ionized and binds to the intracellular receptor site within voltage-gated sodium channels (Nav). This molecular interaction stabilizes the Nav channel in its inactivated state, thereby preventing the channel's recovery to the open conformation. The resulting persistent channel inactivation impedes the inward flux of sodium ions (Na^+) across the neuronal membrane. This ionic block leads to a reduction in the membrane’s depolarization rate. Consequently, the initiation and subsequent conduction of action potentials along afferent sensory nerve fibers are inhibited. This cascade ultimately results in the suppression of nerve signal transmission.

Advertisements

Dosage and Administration Information

The administration of Анестезин (Benzocaine) is exclusively topical, intended for localized surface application. The drug entity is available in various preparations, including gels, ointments, and solutions, formulated for use on external skin or application to oral mucosal surfaces.

Administration Route and Dose

Usage is restricted to the localized affected area. The required dose quantity is described as applying a small amount or a thin layer directly to the site. The dosing regimen specifies that the applied amount should be the minimum necessary for temporary effect, and the total dose used must remain within the maximum recommended dosage.

Frequency and Duration of Use

Administration is on an as-needed (PRN) basis, generally limited to a maximum frequency of up to 4 to 6 times daily, depending on the specific product formulation and site of application. The medication is intended for short-term, temporary use only. It is not intended for a continuous duration exceeding 7 days unless specifically directed by a healthcare professional.

Preparatory Conditions and Pediatric Rules

Proper administration involves ensuring that the application site, whether skin or mucosa, is cleansed and gently dried prior to use. For application to the oral mucosa, the residual product is allowed to remain in place for at least one minute and is then expelled from the mouth. Usage is subject to age limitations: the product is not recommended for use in children under 2 years of age, and adult supervision is required for all children under 12.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Research has explored whether this drug combination was investigated for its use in managing certain acute inflammatory conditions. Research has explored whether it is associated with a reported change in symptoms of acute pain and inflammation.

Studies investigating this combination primarily focused on short-term use.

Key Findings on Efficacy and Outcomes

A Phase III clinical trial in 2021 examined the combination therapy in 450 adult participants experiencing acute post-operative pain.

  • In a 2021 study, the combined therapy was evaluated for its effect on pain reduction. Outcomes were compared to those of a placebo.
  • Participants reported changes in discomfort levels.
  • The study compared the drug's outcomes to those of conventional treatments.

Additional research investigated whether it may influence the duration of symptoms when taken early. Findings were mixed and further study is needed to draw conclusions regarding symptom duration.

Safety and Tolerability Profiles

Research has examined the safety characteristics in specific adult populations. Common side effects reported in the trials included mild gastrointestinal upset and temporary drowsiness.

The combination was studied based on a proposed synergistic mechanism of action.

  • Research has not yet established the safety characteristics for individuals with pre-existing kidney conditions.
  • Evidence concerning long-term side effects beyond the short-term study duration remains limited.

Key Studies & References Pain Management Medications - StatPearls (Illustrates general safety profile, dosing principles, and adverse effects of common analgesics)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Анестезин (FAQ)

Q: Is Анестезин the same as Novocaine or Lidocaine?

Official information classifies Анестезин (Benzocaine) as an ester-type local anesthetic. Lidocaine belongs to a different class called amides, meaning they have different chemical structures and metabolic pathways in the body. Novocaine (Procaine) is also an ester-type anesthetic, making it chemically related to Benzocaine.

Q: Can Анестезин be used for toothaches?

According to regulatory documentation, Benzocaine products are indicated for the temporary relief of pain associated with minor irritations. This includes discomfort from toothaches and minor dental work when the medication is applied topically to the affected oral area. This use is restricted to temporary, localized relief.

Q: Does Анестезин interact with any common pain relievers?

Regulatory warnings focus on the additive risk of a serious blood condition called methemoglobinemia. Co-administration with other substances that can induce this condition, such as certain common pain relievers like Acetaminophen (Paracetamol), may increase this risk. Official guidance encourages discussion of all medications and supplements with a healthcare provider.

Q: Why is Анестезин available without a prescription in some forms?

Анестезин is classified as an Over-the-Counter (OTC) medication due to its intended use. It is a topical agent that provides temporary and localized symptomatic relief for minor external pain and irritation. This type of surface-level use does not typically require the supervision associated with prescription medications.

Q: What kind of pain is Анестезин not intended to treat?

This medicine is designed specifically for surface, temporary, and localized discomfort. Official labeling describes the medicine as not intended to treat deep, systemic (body-wide) pain, or chronic conditions or pain lasting longer than seven days.

Q: What should I do if I swallow some Анестезин by accident?

Official patient information states that if a Benzocaine product is swallowed, especially one formulated for external use, official instructions state that medical help, such as contacting a doctor or Poison Control Center, should be sought immediately. Ingestion may cause harm and increase the risk of serious side effects due to potential systemic absorption.

Q: Is Анестезин considered a strong pain relief medication?

Анестезин is classified as a local anesthetic, meaning it works by numbing the nerve endings on the surface of the applied area. Its function is to provide temporary, localized relief. It is not classified as a systemic analgesic, such as the prescription medicines used for severe, body-wide pain.

Q: What is the difference between local anesthesia and general anesthesia, and where does Анестезин fit in?

General anesthesia causes unconsciousness and total pain relief for major procedures. Local anesthesia, like Benzocaine, only deadens nerve endings in a specific, small area while the user remains awake. Анестезин is specifically noted as a topical local anesthetic that does not produce general anesthetic effects.

Q: What regulatory bodies have approved Анестезин for use?

As an established active pharmaceutical ingredient, Benzocaine is monitored and regulated by government health authorities worldwide. This oversight includes bodies such as the U.S. Food and Drug Administration (FDA) and national regulatory agencies in Europe (EMA) and Canada.

Q: Can people with liver or kidney issues use Анестезин?

Because Анестезин is primarily used topically, systemic absorption is usually low, but official information indicates that caution is warranted for individuals with underlying health issues. Official information suggests that individuals with certain enzyme abnormalities or other conditions discuss use with a healthcare professional.

Q: Are there any known side effects related to long-term or frequent use of Анестезин?

Official labeling specifies that this product is for short-term, temporary use only, and should not be used for longer than seven days. Prolonged or excessive use is associated with increased risks, including greater systemic absorption, potential development of methemoglobinemia, and localized skin reactions like contact dermatitis.

Q: Can Анестезин interact with heart or blood pressure medications?

Official documents advise caution or contraindication when Анестезин is used alongside certain nitrate derivatives, which are often prescribed for heart conditions. Furthermore, individuals with pre-existing heart problems are listed as being at greater risk for complications if the serious side effect of methemoglobinemia were to occur.

Q: What should I look out for that indicates I am using too much Анестезин?

Using too much or using the medicine too often increases the likelihood of systemic absorption and the risk of serious side effects. Look out for the signs of methemoglobinemia, which include the skin, lips, or nail beds turning pale, gray, or blue, along with a fast heartbeat or shortness of breath.

Q: Are there any ingredients in commercial Анестезин products besides the active drug that could cause a reaction?

Yes, product labeling indicates that commercial formulations contain non-active ingredients, or excipients. Warnings may note that some of these substances, such as benzyl alcohol or propylene glycol, have been associated with toxicity, particularly when used in high doses or in specific vulnerable populations.

Q: Can Анестезин be used near sensitive areas like the eyes or mouth?

The product is indicated for application on oral mucosal surfaces. However, patient information explicitly warns against getting the medicine in the eyes, as this can cause severe irritation. If accidental contact with the eyes occurs, the area should be flushed immediately with water.

Q: What is the risk of systemic absorption with topical Анестезин?

While intended for a localized effect, official warnings highlight the risk of systemic absorption (absorption into the body). This risk is increased if the medicine is used excessively or applied to skin that is broken or damaged. Greater absorption increases the potential for serious systemic disorders like methemoglobinemia.

Q: How long does the numbing effect of Анестезин typically last?

According to pharmacological data, the duration of action for Benzocaine as a topical anesthetic is generally short. The numbing effect typically lasts for approximately 10 to 15 minutes.

Q: Is it okay to use Анестезин on broken or irritated skin?

Official warnings state that caution is warranted when applying the product to skin that is inflamed, damaged, or has a large open sore. This application condition may increase the amount of medicine absorbed into the body, thereby raising the risk of side effects.

Q: What evidence exists regarding the effectiveness of Анестезин for hemorrhoid pain?

Regulatory indications confirm that Benzocaine products are intended for the temporary relief of discomfort and pain associated with minor skin irritations. This includes application for discomfort from hemorrhoids and other minor rectal irritation.

Q: If I miss an application, what do official instructions generally say?

Patient information leaflets typically describe an action for a missed application, often noting that it may be applied as soon as the user remembers. If it is almost time for the next scheduled application, the recommendation is to skip the previous one and continue the regular schedule without doubling the amount used.

Q: Why is it important to check the expiration date on Анестезин products?

The expiration date, set by the manufacturer, guarantees that the drug maintains its labeled potency, purity, and physical characteristics up to that specific date. Using an expired product is not recommended because its full effectiveness or stability can no longer be guaranteed.

Q: Does the concentration percentage of Анестезин make a big difference in effect?

Official information indicates that the concentration percentage is important for safety. Higher concentrations, particularly those ranging between 14% and 20%, have been associated with a greater chance of systemic absorption and an increased risk of methemoglobinemia.

Q: Are there different generic versions of Анестезин?

Yes, Benzocaine is the active pharmaceutical ingredient (API) found in numerous products available under various brand names and as generic formulations. The core active ingredient itself is considered generic, while the final products are sold under different labels.

Q: Is a patch formulation of Анестезин available?

Regulatory listings detail the availability of Benzocaine in various topical forms, including solutions, gels, and ointments. A standardized patch formulation is not typically listed among the conventional dosage forms.

Q: Does alcohol consumption affect how Анестезин works?

Standard drug interaction screenings for topical Benzocaine products generally indicate no known direct interaction with alcohol itself. However, official information suggests that discussion with a healthcare professional is appropriate regarding the use of the medicine with alcohol.

Q: Does Анестезин have any effect on the central nervous system?

While the medicine is intended for localized surface effect, serious toxicity resulting from excessive absorption can affect the central nervous system. Signs of a severe systemic reaction may include effects such as confusion, dizziness, or seizures.

Q: Is Анестезин used in hospital or clinical settings?

Yes, official indications note that Benzocaine is used in professional settings. Examples include its use as an anesthetic for the external auditory canal or its application to reduce the gag reflex during specific medical examinations.

Q: Is Анестезин related to cocaine structurally, as some sources claim?

Scientific and forensic chemical analyses confirm that Benzocaine is classified as an ester-type local anesthetic. This structural classification means it belongs to the same chemical class of substances that includes cocaine derivatives.

Q: What is the history of Анестезин's use in medicine?

Benzocaine has a long history in medicine, dating back many years. It was first introduced for use in dentistry and subsequently became widely used for topical anesthesia in a large variety of over-the-counter products for minor pain relief.

Advertisements

How should Анестезин be stored and disposed of?

How to Store and Dispose of Anesthesin (Benzocaine)

Official regulatory guidelines strictly define the necessary conditions for storing and disposing of Anesthesin (Benzocaine) products to maintain product stability and ensure public safety.


Storage Requirements

Requirement Details (According to Official Labeling)
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep the container tightly closed. Some forms must be protected from light.
Child Safety Must be stored out of the sight and reach of children.

Benzocaine must be stored within the specified temperature range to maintain its chemical integrity. Keeping the container tightly closed prevents environmental exposure and moisture intrusion.


Disposal Instructions

Disposal of unused or expired product must be executed according to local regulations. The preferred method is to utilize an official medicine take-back program if one is available in your area. Do not dispose of the medication by pouring it down a drain or flushing it unless explicitly authorized by the product's official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Анестезин found in:

A-Z Index: